Interactive Introduction cost effectiveness
-
Upload
alan-acosta -
Category
Documents
-
view
48 -
download
1
description
Transcript of Interactive Introduction cost effectiveness
![Page 1: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/1.jpg)
Interactive Introduction cost effectiveness
Jan J. v. Busschbach, Ph.DJan J. v. Busschbach, Ph.DViersprong Institute for studies on Personality Viersprong Institute for studies on Personality Disorders (VISPD)Disorders (VISPD)
[email protected]+31 164 632200
Department of Medical Psychology & Department of Medical Psychology & Psychotherapy, Erasmus University Medical Center Psychotherapy, Erasmus University Medical Center
![Page 2: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/2.jpg)
2
New cancer therapy
Symptoms Drug X Drug Y
Survival days 300 400Days sick of chemotherapy 10 150Days sick of disease 100 30TWiST 190 220
![Page 3: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/3.jpg)
3
Time Without Symptoms of disease and subjective Toxic effects of treatment
• TWiST– Developed by Richard Gelber (statistician)
• In search for a typical “cancer” problem– Often prolonged life but also a reductions in
quality of life• At the beginning (side effects)• At the end
– Only count the days without symptoms of disease and subjective toxic effects of the treatment
![Page 4: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/4.jpg)
4
Fit new therapy in fixed budget
• 50 patients each year (per hospital) – Drug x: 50 x euro 1.750 = euro 87.500– Drug y: 50 x euro 2.000 = euro 100.000
• Drug budget for x or y = euro 50.000– Number of patient
• Drug x: euro 50.000 / 1.750 = 28.5 patients• Drug y: euro 50.000 / 2.000 = 25.0 patients
– Survival in days• Drug x: 28.5 patients x 300 days = 8.550 days• Drug y: 25.0 patients x 400 days = 10.000 days
– Survival in TWiST• Drug x: 28.5 patients x 190 TWiST = 5.415 days• Drug y: 25.0 patients x 220 TWiST = 5.500 days
![Page 5: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/5.jpg)
5
TWiST: ignores differences in quality of life
• TWiST– Healthy = 1– Sick (dead) = 0
• There is more to life than sick/health– Make intermediate values– Q-TWiST
• Quality of life adjusted adjusted TWiST• How to scale quality of life?
0.0 Q
uality of lif
e 1
.0
![Page 6: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/6.jpg)
6
Value a health state
• Wheelchair– Some problems in walking about– Some problems washing or dressing– Some problems with performing usual activities– Some pain or discomfort– No psychosocial problems
![Page 7: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/7.jpg)
7
Time Trade-Off
• TTO• Wheelchair
– With a life expectancy: 50 years• How many years would you trade-off for a cure?
– Max. trade-off is 10 years• QALY(wheel) = QALY(healthy)
– Y * V(wheel) = Y * V(healthy)– 50 V(wheel) = 40 * 1
• V(wheel) = .80
![Page 8: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/8.jpg)
8
EuroQol EQ-5D: of the shelf QALY value
• MOBILITY– I have no problems in walking about – I have some problems in walking about – I am confined to bed
• SELF-CARE– I have no problems with self-care – I have some problems washing or dressing myself – I am unable to wash or dress myself
• USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities)
– I have no problems with performing my usual activities – I have some problems with performing my usual
activities – I am unable to perform my usual activities
• PAIN/DISCOMFORT– I have no pain or discomfort – I have moderate pain or discomfort – I have extreme pain or discomfort
• ANXIETY/DEPRESSION– I am not anxious or depressed – I am moderately anxious or depressed – I am extremely anxious or depressed
![Page 9: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/9.jpg)
9
In health economics: Q-TWiST = QALY
• Count life years• Value (V) quality of life (Q)
– V(Q) = [0..1] • 1 = Healthy• 0 = Dead
– One dimension• Adjusted life years (Y) for value quality of life
– QALY = Y * V(Q)• Y: numbers of life years• Q: health state• V(Q): the value of health state Q
• Also called “utility analysis”
![Page 10: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/10.jpg)
10
• A new wheelchair for elderly (iBOT)• Special post natal care
Which health care program is the most cost-effective?
![Page 11: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/11.jpg)
11
Which health care program is the most cost-effective?
• A new wheelchair for elderly– Increases quality of life = 0.1 – 10 years benefit– Extra costs: $ 3,000 per life year– QALY = Y x V(Q) = 10 x 0.1 = 1 QALY– Costs are 10 x $3,000 = $30,000– Cost/QALY = 30,000/QALY
• Special post natal care– Quality of life = 0.8– 35 year– Costs are $250,000– QALY = 35 x 0.8 = 28 QALY– Cost/QALY = 8,929/QALY
![Page 12: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/12.jpg)
12
Effect psychotherapy
0.5
0.6
0.7
0.8
0.9
1.0
Intake 1 year after 2 years
EQ
-5D
soc
ial v
alue
s
Clinic 12 months
Clinic 6 months
Clinic 3 months(STIP)Out-patient clinic
![Page 13: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/13.jpg)
13
Example STIP
• Short-Term Inpatient Psychotherapy• Cost price
– Per patient day: € 210.34– 3 mouths = 91.3 day– 91.3 x 210 = € 19,194.53
• Includes overhead– Buildings, administration, etc
• Excluding– Savings elsewhere in health care system
• Effect– Assume quality of life increase of 0.25– Over 10 year
• Cost / QALY– 19,194.54 / (10 x 0.25) = € 7,677.41
Although gold standard…
Cost per QALY of
psychotherapy have never been
published
![Page 14: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/14.jpg)
14
QALY league table
Intervention $ / QALY GM-CSF in elderly with leukemia 235,958
EPO in dialysis patients 139,623
Lung transplantation 100,957
End stage renal disease management 53,513
Heart transplantation 46,775
Didronel in osteoporosis 32,047
PTA with Stent 17,889
STIP: Short-term inpatient psychotherapy 7,677
Breast cancer screening 5,147
Viagra 5,097
Treatment of congenital anorectal malformations 2,778
![Page 15: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/15.jpg)
15
1.0
0.0A B C
Util
ity o
f Hea
l th
Egalitarian Concerns:Burden of disease
![Page 16: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/16.jpg)
16
Implications shifting threshold
• QALY are weighted• Weighted QALYs are maximized
– Health is no longer the only thing maximized• Health status population will drop• Differences in health will drop
– Egalitarian consideration are incorporated• Burden of disease becomes a criteria
– Equity
![Page 17: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/17.jpg)
17
CE-ratio by equity
![Page 18: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/18.jpg)
18
Burden of disease based on STEP-data (N = 641)
0.0
0.2
0.4
0.6
0.8
1.0
![Page 19: Interactive Introduction cost effectiveness](https://reader035.fdocuments.in/reader035/viewer/2022070502/56813660550346895d9ded1b/html5/thumbnails/19.jpg)
19
Conclusion
• Introduce state-of-the-art cost effectiveness studies– Measure costs and outcome
• Suitable for cost effectiveness studies• According to guidelines
• Establish burden of disease– State-of-the-art quality of life research
• Use an active approach on budget constrains– Anticipate on policy arguments– Look for beyond own discipline